Compound Summary
Compound Name: | N-Acetyldopamine |
Compound CID: | 100526 |
Synonyms: | N-Acetyldopamine 2494-12-4 n-2-(3,4-dihydroxyphenyl)ethylacetamide N-(3,4-Dihydroxyphenethyl)acetamide N-Acetyldopamine monohydrate More... |
Iupac Name: | N-[2-(3,4-dihydroxyphenyl)ethyl]acetamide |
InChI: | InChI=1S/C10H13NO3/c1-7(12)11-5-4-8-2-3-9(13)10(14)6-8/h2-3,6,13-14H,4-5H2,1H3,(H,11,12) |
InChIKey: | OFSAJYZMIPNPHE-UHFFFAOYSA-N |
Canonical Smiles: | CC(=O)NCCC1=CC(=C(C=C1)O)O |
Isomeric Smiles: | CC(=O)NCCC1=CC(=C(C=C1)O)O |
Molecular Weight: | 195.21 |
Molecular Formula: | C10H13NO3 |
Molecular Weight: | 195.21 |
Molecular Formula: | C10H13NO3 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 3 |
Heavy Atom Count: | 14 |
Complexity: | 196 |
N-Acetyldopamine | N-Acetyldopamine |
---|---|
N-Acetyldopamine |
2494-12-4 |
n-2-(3,4-dihydroxyphenyl)ethylacetamide |
N-(3,4-Dihydroxyphenethyl)acetamide |
N-Acetyldopamine monohydrate |
NSC 314644 |
CHEMBL137743 |
Acetamide, N-2-(3,4-dihydroxyphenyl)ethyl- |
Acetamide, N-(2-(3,4-dihydroxyphenyl)ethyl)- |
N-acetyl-dopamine |
7DP |
BRN 2806306 |
Acetamide, N-(3,4-dihydroxyphenethyl)- |
Lopac-A-8762 |
Acetamide,N-2-(3,4-dihydroxyphenyl)ethyl- |
Lopac0_000093 |
SCHEMBL328568 |
Acetamide, N-(3,4-dihydroxyphenethyl)- (7CI,8CI) |
Acetamide,4-dihydroxyphenethyl)- |
DTXSID70179656 |
CHEBI:125678 |
ZINC402700 |
CAA49412 |
HY-N7493 |
Acetamide,4-dihydroxyphenyl)ethyl- |
BDBM50035608 |
MFCD00037174 |
NSC314644 |
AKOS003589558 |
N-(3,4-Dihydroxyphenethyl)-Acetamide |
CCG-204188 |
NSC-314644 |
VZ33103 |
NCGC00015101-01 |
NCGC00015101-02 |
NCGC00015101-03 |
NCGC00093595-01 |
NCGC00093595-02 |
AS-56736 |
CS-0130036 |
EU-0100093 |
A 8762 |
D70944 |
{N-2-(3,} 4-dihydroxyphenyl)ethyl-Acetamide |
N-2-(3,4-dihydroxyphenyl)ethylethanimidic acid |
SR-01000075692 |
SR-01000075692-1 |
BRD-K95847244-001-01-9 |
Q27216289 |
N-(2-(3,4-Dihydroxyphenyl)ethyl)acetamide (ACD/Name 4.0) |
Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33.000000000000000 | umol/L | 6.000000000000000 | NS | N2 | 24134630 | Inactive |
Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 6.000000000000000 | 1 | 1 |